Exploring New Drug Research and Development at the 6th Tokyo Medical Institute Citizen Lecture

6th Tokyo Medical Institute Citizen Lecture: New Drug Research and Development

The 6th Citizen Lecture organized by the Tokyo Medical Institute will take place on November 7, 2025. The focus of this year's lecture will be on "New Drug Research and Development". This initiative aims to share crucial information with the public regarding significant yet unresolved diseases such as neurological conditions, mental disorders, cancer, and infectious diseases, all of which the institute actively researches to develop preventive and therapeutic measures.

The event plans to welcome Dr. Sayuri Watanabe from Janssen Pharmaceuticals to discuss this significant topic.

Event Details

1. Date: November 7, 2025, from 3:00 PM to 4:30 PM
2. Format: Hybrid event hosted both in-person and via the web conferencing platform, Zoom.

Lecture Topic

The lecture will be titled "New Drug Research and Development: How Are New Drugs Made? The Story of Dementia Drug Development". Dr. Watanabe is a project leader in the Global Development Asia Pacific faction of Johnson & Johnson Innovative Medicine.

Speaker Background: Dr. Sayuri Watanabe holds a doctorate in pharmaceutical sciences and manages projects focusing on drug development.

Lecture Overview

Research and development of new medications represent a critical process through which pharmaceutical companies strive to provide patients with innovative treatments. Recently, there has been heightened attention on newly developed medications aimed at treating dementia. Specifically, these medications are credited with the potential to delay the decline in memory and judgment skills in individuals at the early stages of dementia.

In drug development, clinical trials, known as "shiken" in Japanese, play an essential role. These trials assess the safety and efficacy of new drugs. Individuals who are interested can contribute to advancing new therapies by participating in such trials, which can also assist in their personal health management. This lecture aims to shed light on the daily challenges faced by researchers in pharmaceutical companies as they navigate the drug development process while sharing the latest advancements in the field.

Participation Information

The event has a total capacity of 600 attendees: 100 in-person and 500 online. Participation is free but requires advance registration on a first-come, first-served basis.

How to Register

Whether selecting in-person attendance or the Zoom webinar, non-residents of Tokyo are also welcome to apply.

For In-Person Attendance:

- Mail or email your application.
- By Mail: Please send a postcard marked with "6th Citizen Lecture (In-Person Preference)" including your address, name (with furigana), age, phone number, and, if applying for multiple individuals, the names and ages of accompanying persons to the following address:

Application Address: 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Public Relations Section, Tokyo Medical Institute.

- By Email: Use the subject line "6th Citizen Lecture (In-Person Preference)" and provide your name (with furigana), age, phone number, and accompanying persons' information to the designated application email ([email protected]).